Метаболический синдром, когнитивные нарушения, роль питания

Старение населения способствует росту заболеваемости метаболическим синдромом (МС), сердечно-сосудистой патологией, нейродегенеративными заболеваниями, когнитивными нарушениями. Компоненты МС (висцеральное ожирение, артериальная гипертензия, дислипидемия, нарушения углеводного обмена) тесно связаны с питанием и появляются до развития когнитивных нарушений. По данным ряда авторов, средиземноморская диета положительно влияет на сердечно-сосудистую систему, может предотвратить когнитивную дисфункцию. Кроме того, известно, что употребление ряда продуктов питания оказывает терапевтический эффект на компоненты метаболического синдрома, может улучшить когнитивный статус. В тоже время, в литературе встречаются неоднозначные мнения на этот счет. В связи с этим, данная работа посвящена анализу имеющихся данных о связи между МС и его компонентами с когнитивными нарушениями, а также роли питания в профилактике и лечении данных патологий.

метаболический синдром, деменция, когнитивные нарушения, питание, диета, здоровое старение, сахарный диабет, болезнь Альцгеймера

1. do Vale Moreira N.C., Hussain A., Bhowmik B. et al. Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab. Syndr. 2020;14:1217-1224. doi: 10.1016/j.dsx.2020.05.043.

2. Centers for Disease Control and Prevention National Diabetes Statistics Report; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: Atlanta, GA, USA, 2020. Available online: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

3. Saeedia P., Petersohna I., Salpeaet P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9thedition: Diabetes Research and Clinical Practice. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.

4. Assuncao N., Sudo F.K., Drummond C. et al. Metabolic syndrome and cognitive decline in the elderly: A systematic review. PLoS ONE. 2018;13: e0194990. doi: 10.1371/journal.pone.0194990.

5. Chahine L.M., Dos Santos C., Fullard M. et al. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson’s disease. Eur. J. Neurol. 2019;26:246-e18. doi: 10.1111/ene.13797.

6. Castro-Barquero S., Ruiz-León A.M., Sierra-Pérez M. et al. Dietary strategies for metabolic Syndrome: A Comprehensive review. Nutrients. 2020;12:2983. doi: 10.3390/nu12102983,

7. Sharonova L.A., Bulgakova S.V., Dolgikh Yu.A., Kosareva O.V., Treneva E.V., Kurmaev D.P. Obesity as a main component of metabolic syndrome and a risk factor for comorbidity. Experimental and Clinical Gastroenterology. 2024;(2):101-110. (In Russ.) doi: 10.31146/1682-8658-ecg-222-2-101-110.@@ Шаронова Л.А., Булгакова С.В., Долгих Ю.А. и др. Ожирение как основной компонент метаболического синдрома и фактор риска коморбидности. Экспериментальная и клиническая гастроэнтерология. 2024;2(222):101-110. doi: 10.31146/1682-8658-ecg-222-2-101-110.

8. Ramezani-Jolfaie N., Mohammadi M., Salehi-Abargouei A. The effect of healthy nordic diet on cardio-metabolic markers: A systematic review and meta-analysis of randomized controlled clinical trials. Eur. J. Nutr. 2019;58:2159-2174. doi: 10.1007/s00394-018-1804-0.

9. Schwingshackl L., Bogensberger B., Hoffmann G. Diet quality as assessed by the healthy eating index, alternate Healthy eating index, dietary approaches to stop hypertension score, and health outcomes: An updated systematic review and meta-analysis of cohort studies. J. Acad. Nutr. Diet. 2018;118:74-100. doi: 10.1016/j.jand.2017.08.024.

10. Power R., Nolan J.M., Prado-Cabrero A. et al. Targeted nutritional intervention for patients with mild cognitive impairment: The cognitive ImpAiRmEnt study (CARES) Trial 1. J. Pers. Med. 2020;10:43. doi: 10.3390/jpm10020043.

11. Solfrizzi V., Custodero C., Lozupone M. et al. Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: A systematic review. J. Alzheimers Dis. 2017;59:815-849. doi: 10.3233/JAD-170248.

12. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Clinical guidelines on frailty.Russian Journal of Geriatric Medicine. 2020;(1):11-46. (In Russ.) doi: 10.37586/2686-8636-1-2020-11-46.@@ Ткачева О.Н., Котовская Ю.В., Рунихина Н.К. и др. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020;(1):11-46. doi: 10.37586/2686-8636-1-2020-11-46.

13. Bulgakova S.V., Kurmaev D.P., Treneva E.V. et al. Cognitive functions in elderly patients with type 2 diabetes mellitus. Modern problems of health care and medical statistics. 2023;3:286-305. doi: 10.24412/2312-2935-2023-3-286-305.@@ Булгакова С.В., Курмаев Д.П., Тренева Е.В. и др. Когнитивные функции у пациентов с сахарным диабетом 2 типа пожилого возраста. Современные проблемы здравоохранения и медицинской статистики. 2023;3:286-305. doi: 10.24412/2312-2935-2023-3-286-305.

14. Zuin M., Roncon L., Passaro A. et al. Metabolic syndrome and the risk of late onset Alzheimer’s disease: An updated review and meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2021;31:2244-2252. doi: 10.1016/j.numecd.2021.03.020.

15. Yu J.T., Xu W., Tan C.C. et al. Evidence-based prevention of Alzheimer’s disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J. Neurol. Neurosurg. Psychiatry. 2020;91:1201-1209. doi: 10.1136/jnnp-2019-321913.

16. Xue M., Xu W., Ou Y.N. et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res. Rev. 2019;55:100944. doi: 10.1016/j.arr.2019.100944.

17. Pedditzi E., Peters R., Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: A systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016;45:14-21. doi: 10.1093/ageing/afw095.

18. Livingston G., Huntley J., Sommerlad A. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet commission. Lancet. 2020;396:413-446. doi: 10.1016/S0140-6736(20)30367-6.

19. Sui S.X., Pasco J.A. Obesity and brain function: The brain-body crosstalk. Medicina. 2020;56:499. doi: 10.3390/medicina56100499.

20. Kurmaev D.P., Bulgakova S.V., Treneva E.V. Insulin resistance, type 2 diabetes mellitus and sarcopenia. Experimental and Clinical Gastroenterology. 2024;(2):141-148. (In Russ.) doi: 10.31146/1682-8658-ecg-222-2-141-148.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В. Инсулинорезистентность, сахарный диабет 2 типа и саркопения. Экспериментальная и клиническая гастроэнтерология. 2024;(2):141-148. doi: 10.31146/1682-8658-ecg-222-2-141-148.

21. Torres-Perez E., Ledesma M., Garcia-Sobreviela M.P. et al. Apolipoprotein E4 association with metabolic syndrome depends on body fatness. Atherosclerosis. 2016;245:35-42. doi: 10.1016/j.atherosclerosis.2015.11.029.

22. Dionysopoulou S., Charmandari E., Bargiota A. et al. The role of hypothalamic Inflammation in diet-induced obesity and its association with cognitive and mood disorders. Nutrients. 2021;13:498. doi: 10.3390/nu13020498.

23. Wu H., Ballantyne C.M. Metabolic inflammation and insulin resistance in obesity. Circ. Res. 2020;126:1549-1564. doi: 10.1161/CIRCRESAHA.119.31589.

24. Sergi D., Renaud J., Simola N. et al. Diabetes, a contemporary risk for parkinson’s disease: Epidemiological and cellular evidences. Front. Aging Neurosci. 2019;11:302. doi: 10.3389/fnagi.2019.00302.

25. Tups A., Benzler J., Sergi D. et al. Central regulation of glucose homeostasis.Compr. Physiol. 2017;7:741-764. doi: 10.1002/cphy.c160015.

26. Mergenthaler P., Lindauer U., Dienel G.A. et al. Sugar for the brain: The role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36:587-597. doi: 10.1016/j.tins.2013.07.001.

27. Jacob R.J., Fan X., Evans M.L. et al. Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: No evidence for protective adaptation by the blood brain barrier. Metabolism. 2002;51:1522-1524. doi: 10.1053/meta.2002.36347.

28. Tomlinson D.R., Gardiner N.J. Glucose neurotoxicity. Nat. Rev. Neurosci. 2008;9:36-45. doi: 10.1038/nrn2294.

29. de la Monte S.M. Insulin resistance and neurodegeneration: Progress towards the development of new therapeutics for Alzheimer’s disease. Drugs. 2017;77:47-65. doi: 10.1007/s40265-016-0674-0.

30. Bulgakova S.V., Romanchuk P.I., Treneva E.V. Insulin, brain, Alzheimer’s disease: new data. Bulletin of Science and Practice. 2020;6(3):96-126. doi: 10.33619/2414-2948/52/10.@@ Булгакова С.В., Романчук П.И., Тренева Е.В. Инсулин, головной мозг, болезнь Альцгеймера: новые данные. Бюллетень науки и практики. 2020;6(3):96-126. doi: 10.33619/2414-2948/52/10.

31. Sergi D., Williams L.M. Potential relationship between dietary long-chain saturated fatty acids and hypothalamic dysfunction in obesity. Nutr. Rev. 2020;78:261-277. doi: 10.1093/nutrit/nuz056.

32. Ekblad L.L., Rinne J.O., Puukka P. et al. Insulin resistance predicts Cognitive decline: An 11-year follow-up of a nationally representative adult population sample. Diabetes Care. 2017;40:751-758. doi: 10.2337/dc16-2001.

33. Willmann C., Brockmann K., Wagner R. et al. Insulin sensitivity predicts cognitive decline in individuals with prediabetes. BMJ Open Diabetes Res. Care. 2020;8: e001741 doi: 10.1136/bmjdrc-2020-001741.

34. Frisardi V., Solfrizzi V., Capurso C. et al. Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J. Alzheimers Dis. 2010;21:57-63. doi: 10.3233/JAD-2010-100015.

35. Reiman E.M., Caselli R.J., Yun L.S. et al. Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.N. Engl. J. Med. 1996;334:752-758. doi: 10.1056/NEJM199603213341202.

36. Zhong K.L., Chen F., Hong H. et al. New views and possibilities of antidiabetic Drugs in treating and/or preventing mild cognitive impairment and Alzheimer’s disease. Metab. Brain Dis. 2018;33:1009-1018. doi: 10.1007/s11011-018-0227-1.

37. Ou Y.N., Tan C.C., Shen X.N. et al. Blood pressure and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76:217-225. doi: 10.1161/HYPERTENSIONAHA.120.149,

38. Hughes D., Judge C., Murphy R. et al. Association of blood pressure lowering with Incident dementia or cognitive impairment: A systematic review and meta-analysis. JAMA. 2020;323:1934-1944. doi: 10.1001/jama.2020.4249.

39. Rensma S.P., van Sloten T.T., Houben A.J.H.M. et al. Microvascular dysfunction is associated with worse Cognitive performance. Hypertension. 2020;75:237-245. doi: 10.1161/HYPERTENSIONAHA.119.1302.

40. Mellor D.D., Georgousopoulou E.N., D’Cunha N.M. et al. ATTICA study group association between lipids and apolipoproteins on type 2 diabetes risk; moderating Effects of gender and polymorphisms; the ATTICA study. Nutr. Metab. Cardiovasc. Dis. 2020;30:788-795. doi: 10.1016/j.numecd.2020.01.008.

41. Ohtani R., Nirengi S., Nakamura M. et al. High-density lipoprotein subclasses and mild cognitive impairment: Study of outcome and APolipoproteins in dementia (STOP-Dementia)1. J. Alzheimers Dis. 2018;66:289-296. doi: 10.3233/JAD-180135.

42. Chernick D., Zhong R., Li L. The role of HDL and HDL mimetic peptides as potential therapeutics for Alzheimer’s disease. Biomolecules. 2020;10:1276. doi: 10.3390/biom10091276,

43. Nordestgaard L.T., Christoffersen M., Afzal S. et al. Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: A study of 125,727 individuals. Clin. Chem. 2021;67:245-255. doi: 10.1093/clinchem/hvaa269.

44. Siervo M., Harrison S.L., Jagger C. et al. Metabolic syndrome and longitudinal changes in cognitive Function: A systematic review and meta-analysis. J. Alzheimers Dis. 2014;41:151-161. doi: 10.3233/JAD-132279.

45. Hardman R.J., Kennedy G., Macpherson H. et al. Adherence to a Mediterranean-style diet and effects on cognition in adults: A qualitative evaluation and systematic review of longitudinal and prospective trials. Front. Nutr. 2016;3:22. doi: 10.3389/fnut.2016.00022.

46. Wu J., Song X., Chen G.C. et al. Dietary pattern in midlife and cognitive impairment in Late life: A prospective study in Chinese adults. Am.J. Clin. Nutr. 2019;110:912-920. doi: 10.1093/ajcn/nqz150.

47. Shannon O.M., Stephan B.C.M., Granicm A. et al. Mediterranean diet adherence and cognitive function in older UK adults: The European prospective Investigation into cancer and nutrition-norfolk (epic-Norfolk) study. Am.J. Clin. Nutr. 2019;110:938-948. doi: 10.1093/ajcn/nqz114.

48. Andreu-Reinón M.E., Chirlaque M.D., Gavrila D. et al. Mediterranean diet and risk of dementia and Alzheimer’s disease in the EPIC-Spain dementia cohort study. Nutrients. 2021;13:700. doi: 10.3390/nu13020700.

49. McEvoy C.T., Hoang T., Sidney S. et al. Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study. Neurology. 2019;92: e1589-e1599. doi: 10.1212/WNL.0000000000007243.

50. Zhang H., Hardie L., Bawajeeh A.O. et al. Meat consumption, cognitive function and disorders: A systematic review with narrative synthesis and meta-analysis. Nutrients. 2020;12:1528. doi: 10.3390/nu12051528.

51. Filippou C.D., Thomopoulos C.G., Kouremeti M.M. et al. Mediterranean diet and blood pressure reduction in adults with and without hypertension: A systematic review and meta-Analysis of randomized controlled trials. Clin. Nutr. 2021;40:3191-3200. doi: 10.1016/j.clnu.2021.01.030.

52. Martínez-Lapiscina E.H., Clavero P., Toledo E. et al. Mediterranean diet Improves cognition: The PREDIMED-NAVARRA randomised trial. J. Neurol. Neurosurg. Psychiatry. 2013;84:1318-1325. doi: 10.1136/jnnp-2012-304792.

53. Canudas S., Becerra-Tomás N., Hernández-Alonso P. et al. Mediterranean diet and telomere length: A systematic review and meta-analysis. Adv. Nutr. 2020;11:1544-1554. doi: 10.1093/advances/nmaa079.

54. Trichopoulou A., Kyrozis A., Rossi M. et al. Mediterranean diet and cognitive decline over time in an elderly mediterranean population. Eur. J. Nutr. 2015;54:1311-1321. doi: 10.1007/s00394-014-0811-z.

55. Rajaram S., Jones J., Lee G.J. Plant-based dietary patterns, plant foods, and age-related cognitive decline. Adv. Nutr. 2019;10: S422-S436. doi: 10.1093/advances/nmz081.

56. Shin J.Y., Kim J., Kang H.T. et al. Effect of fruits and vegetables on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.Int. J. Food Sci. Nutr. 2015;66:416-425. doi: 10.3109/09637486.2015.1025716.

57. Qin B., Adair L.S., Plassman B.L. et al. Dietary patterns and cognitive decline among Chinese older adults. Epidemiology. 2015;26:758-768. doi: 10.1097/EDE.0000000000000338.

58. Ozawa M., Shipley M., Kivimaki M. et al. Dietary pattern inflammation and cognitive decline: The Whitehall II prospective cohort study. Clin. Nutr. 2017;36:506-512. doi: 10.1016/j.clnu.2016.01.013.

59. Bulgakova S.V., Romanchuk N.P., Treneva E.V. Microbiome and brain: intestinal microbiota and neuroendocrine system. Bulletin of Science and Practice. 2022;8(6):261-307. doi: 10.33619/2414-2948/79/32.@@ Булгакова С.В., Романчук Н.П., Тренева Е.В. Микробиом и мозг: кишечная микробиота и нейроэндокринная система. Бюллетень науки и практики. 2022;8(6):261-307. doi: 10.33619/2414-2948/79/32.

60. Berding K., Carbia C., Cryan F. Going with the grain: Fiber, cognition, and the microbiota-gut-brain-axis. Exp. Biol. Med. 2021;246:796-811. doi: 10.1177/1535370221995785.

61. Lin P.Y., Chiu C.C., Huang S.Y. et al. A Meta-analytic review of polyunsaturated fatty acid compositions in dementia. J. Clin. Psychiatry. 2012;73:1245-1254. doi: 10.4088/JCP.11r07546.

62. Karimi G., Heidari Z., Firouzi S. et al. A systematic review and meta-analysis of the association between fish consumption and risk of metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2020;30:717-729. doi: 10.1016/j.numecd.2020.02.001.

63. Kurmaev D.P., Bulgakova S.V., Treneva E.V. et al. Nutritional support in a comprehensive program of prevention and treatment of sarcopenia.Russian Journal of Geriatric Medicine. 2023;(1):29-38. (In Russ.) doi: 10.37586/2686-8636-1-2023-29-38.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В., и др. Нутритивная поддержка в комплексной программе профилактики и лечения саркопении. Российский журнал гериатрической медицины. 2023;(1):29-38. doi: 10.37586/2686-8636-1-2023-29-38.

64. Kawahara M., Tanaka I., Kato-Negishi M. Zinc, carnosine, and neurodegenerative diseases. Nutrients. 2018;10:147. doi: 10.3390/nu10020147.

65. Lane D.J.R., Ayton S., Bush A.I. Iron and Alzheimer’s disease: An update on emerging mechanisms. J. Alzheimers Dis. 2018;64: S379-S395. doi: 10.3233/JAD-179944.

66. Zhang H., Greenwood D.C., Risch H.A. et al. Meat consumption and risk of incident dementia: Cohort study of 493,888 UK Biobank participants. Am.J. Clin. Nutr. 2021;114:175-184. doi: 10.1093/ajcn/nqab028.

67. Zhao X., Yuan L., Feng L. et al. Association of dietary intake and lifestyle Pattern with mild cognitive impairment in the elderly. J. Nutr. Health Aging. 2015;19:164-168. doi: 10.1007/s12603-014-0524-2.

68. Li Y., Li S., Wang W. et al. Association between dietary protein intake and cognitive function in adults aged 60 years and older. J. Nutr. Health Aging. 2020;24:223-229. doi: 10.1007/s12603-020-1317-4.

69. Cui C., Birru R.L., Snitz B.E. et al. Effects of soy isoflavones on cognitive function: A systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 2020;78:134-144. doi: 10.1093/nutrit/nuz050.

70. Xu X., Xiao S., Rahardjo T.B. et al. Tofu intake is associated with poor cognitive performance among community-dwelling elderly in China. J. Alzheimers Dis. 2015;43:669-675. doi: 10.3233/JAD-141593.

71. Theodore L.E., Kellow N.J., McNeil E.A. et al. Nut consumption for cognitive performance: A systematic review. Adv. Nutr. 2021;12:777-792. doi: 10.1093/advances/nmaa153.

72. Wu L., Sun D. Meta-analysis of milk consumption and the risk of cognitive disorders. Nutrients. 2016;8:824. doi: 10.3390/nu8120824.

73. Bermejo-Pareja F., Ciudad-Cabañas M.J., Llamas-Velasco S. et al. Is milk and dairy intake a preventive factor for elderly cognition (dementia and Alzheimer’s)? A quality review of cohort surveys. Nutr. Rev. 2021;79:743-757. doi: 10.1093/nutrit/nuaa045.

74. Ano Y., Nakayama H. Preventive effects of dairy products on dementia and the underlying mechanisms.Int. J. Mol. Sci. 2018;19:1927. doi: 10.3390/ijms19071927.

75. Zhu R.Z., Chen M.Q., Zhang Z.W. et al. Dietary fatty acids and risk for Alzheimer’s disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis. Nutrition. 2021;90:111355. doi: 10.1016/j.nut.2021.111355.

76. Román G., Jackson R.E., Reis J. et al. Extra-virgin olive oil for potential prevention of Alzheimer disease. Rev. Neurol. 2019;175:705-723. doi: 10.1016/j.neurol.2019.07.017.

77. Larsson S.C., Orsini N. Coffee consumption and risk of dementia and Alzheimer’s disease: A dose-response meta-analysis of prospective studies. Nutrients. 2018;10:1501. doi: 10.3390/nu10101501.

78. Ding M., Satija A., Bhupathiraju S.N. et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015;132:2305-2315. doi: 10.1161/CIRCULATIONAHA.115.01734.

79. Colombo R., Papetti A. An outlook on the role of decaffeinated coffee in neurodegenerative diseases. Crit. Rev. Food Sci. Nutr. 2020;60:760-779. doi: 10.1080/10408398.2018.1550384.

80. Williams J.L., Everett J.M., D’Cunha N.M. et al. The effects of green tea amino acid L-theanine consumption on the ability to manage stress and anxiety levels: A systematic review. Plant Foods Hum. Nutr. 2020;75:12-23. doi: 10.1007/s11130-019-00771-5.

81. Cornelis M.C., Weintraub S., Morris M.C. Caffeinated coffee and tea consumption, genetic variation and cognitive function in the UK Biobank. J. Nutr. 2020;150:2164-2174. doi: 10.1093/jn/nxaa147.

82. Bulgakova S.V., Romanchuk N.P., Pomazanova O.S. Psychoneuroimmunoendocrinology and Immune Homeostasis: Gut-brain Axis, Obesity and Cognitive Function. Bulletin of Science and Practice. 2020;6(12):124-1546. (in Russ.) doi: 10.33619/2414-2948/61/15.@@ Булгакова С.В., Романчук Н.П., Помазанова О.С. Психонейроиммуноэндокринология и иммунный гомеостаз: ось кишечник-головной мозг, ожирение и когнитивные функции. Бюллетень науки и практики. 2020;6(12):124-154. doi: 10.33619/2414-2948/61/15.

83. Den H., Dong X., Chen M. et al. Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment - A meta-analysis of randomized controlled trials. Aging. 2020;12:4010-4039. doi: 10.18632/aging.102810.

84. Marx W, Scholey A, Firth J. et al. Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials. Neurosci. Biobehav. Rev. 2020;118:472-484. doi: 10.1016/j.neubiorev.2020.07.036.

85. Bulgakova S.V., Romanchuk N.P. Immune Homeostasis: New Role of Micro- and Macroelements, Healthy Microbiota. Bulletin of Science and Practice. 2020;6(10):206-2336 (in Russ.) doi: 10.33619/2414-2948/59/22.@@ Булгакова С.В., Романчук Н.П. Иммунный гомеостаз: новая роль микро- и макроэлементов, здоровой микробиоты. Бюллетень науки и практики. 2020;6(10):206-233. doi: 10.33619/2414-2948/59/22.